Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001104659-25-062191
Filing Date
2025-06-24
Accepted
2025-06-24 18:35:41
Documents
1
Period of Report
2025-06-20

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2518838-1_4seq1.html 4  
1 OWNERSHIP DOCUMENT tm2518838-1_4seq1.xml 4 6724
  Complete submission text file 0001104659-25-062191.txt   8194
Mailing Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878
Business Address 700 QUINCE ORCHARD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

EIN.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address C/O MERCK & CO INC ONE MERCK DRIVE PO BOX 100 WHITEHOUSE STATION NJ 08889-0100
Business Address
MCGLYNN MARGARET G (Reporting) CIK: 0001215126 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 251070445